Description
Recently, mRNA vaccines have drawn extensive attention due to its potency to tackle various unmet therapeutical issues that are unable to be solved by traditional vaccine technologies. For example, live-attenuated vaccines sometimes exhibit safety drawbacks that could potentially induce pathogenic diseases. While subunit vaccines have been developed as an improved safe alternative, they are less efficient and mostly take effect in the presence of adjuvants.